Insiders who reported open-market trades in the last 12 months at the companies Travis Alvin Thompson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Kevin Lee - $98K in BCYC purchases and sales in the last 12 months
Michael Skynner - $31K in BCYC purchases and sales in the last 12 months
Travis Alvin Thompson is a corporate insider, tracked as Chief Financial Officer of BICYCLE THERAPEUTICS PLC (BCYC). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Travis Alvin Thompson submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Travis Alvin Thompson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 17 open-market sales ($177K) across all tracked filings.
Travis Alvin Thompson is Chief Financial Officer of BICYCLE THERAPEUTICS PLC (BCYC). 9 SEC Form 4 filings on record going back to 2024, most recently on 6 October 2026. Most recent open-market trade: sold $282 of BCYC on 6 October 2026. Lifetime open-market sales: $177K.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Travis Alvin Thompson.
InsiderAlpha's records for Travis Alvin Thompson go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. 12 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
